Literature DB >> 19502748

Oral supplementation with dihomo-gamma-linolenic acid-enriched oil altered serum fatty acids in healthy men.

Naoya Teraoka1, Hiroshi Kawashima, Akiko Shiraishi-Tateishi, Takao Tanaka, Junichi Nakamura, Saki Kakutani, Yoshinobu Kiso.   

Abstract

Dihomo-gamma-linolenic acid (DGLA)-enriched oil (50 or 150 mg as free DGLA) was administered to healthy men for 4 weeks. The DGLA content in serum phospholipids dose-dependently increased and returned to the initial level after a 4-week washout. No side effects or changes in platelet aggregation were observed. These results indicate that oral supplementation with DGLA oil can safely increase serum DGLA content.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502748     DOI: 10.1271/bbb.90112

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Oral supplementation with dihomo-γ-linolenic acid (DGLA)-enriched oil increases serum DGLA content in healthy adults.

Authors:  Takao Tanaka; Saki Kakutani; Chika Horikawa; Hiroshi Kawashima; Yoshinobu Kiso
Journal:  Lipids       Date:  2012-03-14       Impact factor: 1.880

2.  Serum fatty acids and progression from dengue fever to dengue haemorrhagic fever/dengue shock syndrome.

Authors:  Eduardo Villamor; Luis A Villar; Anyela Lozano-Parra; Víctor M Herrera; Oscar F Herrán
Journal:  Br J Nutr       Date:  2018-08-14       Impact factor: 3.718

3.  Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis.

Authors:  Hayley Gallagher; Jessica O Williams; Nele Ferekidis; Alaa Ismail; Yee-Hung Chan; Daryn R Michael; Irina A Guschina; Victoria J Tyrrell; Valerie B O'Donnell; John L Harwood; Inna Khozin-Goldberg; Sammy Boussiba; Dipak P Ramji
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-06-13       Impact factor: 5.187

Review 4.  Multiple roles of dihomo-γ-linolenic acid against proliferation diseases.

Authors:  Xiaoping Wang; Huanping Lin; Yan Gu
Journal:  Lipids Health Dis       Date:  2012-02-14       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.